<DOC>
	<DOC>NCT02025426</DOC>
	<brief_summary>Phenylephrine administration is associated with reductions in CO and SctO2 compared with ephedrine when used for blood pressure management in women with pre-eclampsia undergoing cesarean delivery under spinal anesthesia.</brief_summary>
	<brief_title>Phenylephrine Versus Ephedrine in Pre-eclampsia</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<criteria>English speaking Age â‰¥18 yrs Preeclampsia (mild, or severe) Nonlaboring women CD under spinal anesthesia Height &lt; 5'0" Allergy to phenylephrine or ephedrine, or any other standardized medication Severe Cardiac disease in pregnancy with marked functional limitations (NYHA Class III and IV) Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants History of recent amphetamine or cocaine use. Subject enrollment in another study involving a study medication within 30 days of CD Any other physical or psychiatric condition which may impair their ability to cooperate with study data collection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cesarean delivery</keyword>
	<keyword>Spinal Anesthesia</keyword>
</DOC>